Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Bond ETF
BSV
|
+$1.77B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.52B |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$1.18B |
| 4 |
iShares Russell 1000 Growth ETF
IWF
|
+$947M |
| 5 |
Zoetis
ZTS
|
+$787M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
UnitedHealth
UNH
|
+$2.39B |
| 2 |
NVIDIA
NVDA
|
+$2.32B |
| 3 |
Microsoft
MSFT
|
+$2.06B |
| 4 |
Apple
AAPL
|
+$1.62B |
| 5 |
Vanguard Total Bond Market
BND
|
+$1.51B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.47% |
| 2 | Financials | 11.66% |
| 3 | Consumer Discretionary | 8.63% |
| 4 | Communication Services | 7.31% |
| 5 | Healthcare | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
J&J Snack Foods
JJSF
$1.43B
| $41.6M | ﹤0.01% |
366,468
-210,594
| -36% | -$25.6M |
|
2102
iShares US Healthcare Providers ETF
IHF
$1.21B
| $41.6M | ﹤0.01% |
854,145
+66,022
| +8% | +$3.25M |
|
2103
AnaptysBio
ANAB
$1.58B
| $41.5M | ﹤0.01% |
1,869,840
+1,365,204
| +271% | +$28.6M |
|
2104
State Street SPDR MSCI USA StrategicFactors ETF
QUS
$1.53B
| $41.4M | ﹤0.01% |
254,010
+5,841
| +2% | +$910K |
|
2105
SentinelOne
S
$6.53B
| $41.4M | ﹤0.01% |
2,265,865
+343,835
| +18% | +$6.29M |
|
2106
Global X Cybersecurity ETF
BUG
$1.28B
| $41.4M | ﹤0.01% |
1,116,401
+217,443
| +24% | +$7.45M |
|
2107
Cohen & Steers Duration Preferred & Income Fund
LDP
$598M
| $41.3M | ﹤0.01% |
1,968,151
+123,813
| +7% | +$2.48M |
|
2108
State Street SPDR S&P 400 Mid Cap Growth ETF
MDYG
$2.8B
| $41.2M | ﹤0.01% |
474,093
-100,705
| -18% | -$8.23M |
|
2109
Academy Sports + Outdoors
ASO
$2.94B
| $41.1M | ﹤0.01% |
916,908
+56,089
| +7% | +$2.32M |
|
2110
Bio-Rad Laboratories Class A
BIO
$8.71B
| $41M | ﹤0.01% |
170,103
-26,521
| -13% | -$6.27M |
|
2111
APi Group
APG
$17.1B
| $41M | ﹤0.01% |
1,203,935
+244,107
| +25% | +$6.99M |
|
2112
UFP Industries
UFPI
$4.9B
| $40.8M | ﹤0.01% |
411,130
+9,112
| +2% | +$919K |
|
2113
JPMorgan BetaBuilders Europe ETF
BBEU
$9.35B
| $40.8M | ﹤0.01% |
605,503
+244,970
| +68% | +$15.8M |
|
|
BTX
2114
BlackRock Technology and Private Equity Term Trust
BTX
$940M
| $40.8M | ﹤0.01% |
5,560,989
-177,173
| -3% | -$1.17M |
|
2115
Flowers Foods
FLO
$1.49B
| $40.7M | ﹤0.01% |
2,546,111
+539,699
| +27% | +$9.3M |
|
2116
BlackRock Debt Strategies Fund
DSU
$593M
| $40.6M | ﹤0.01% |
3,845,572
-75,861
| -2% | -$781K |
|
2117
FlexShares Morningstar US Market Factors Tilt Index Fund
TILT
$2.19B
| $40.6M | ﹤0.01% |
181,205
+12,335
| +7% | +$2.57M |
|
2118
Stoke Therapeutics
STOK
$1.8B
| $40.6M | ﹤0.01% |
3,573,976
-16,849
| -0.5% | -$160K |
|
2119
Alpha Metallurgical Resources
AMR
$1.74B
| $40.5M | ﹤0.01% |
360,473
+209,757
| +139% | +$24.5M |
|
2120
Concentrix
CNXC
$1.5B
| $40.5M | ﹤0.01% |
766,977
-68,714
| -8% | -$3.63M |
|
2121
IES Holdings
IESC
$14.8B
| $40.5M | ﹤0.01% |
136,618
-71,033
| -34% | -$16.7M |
|
2122
10x Genomics
TXG
$6B
| $40.4M | ﹤0.01% |
3,486,955
+712,864
| +26% | +$6.5M |
|
|
GBAB
2123
Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust
GBAB
$382M
| $40.4M | ﹤0.01% |
2,684,676
+157,007
| +6% | +$2.35M |
|
|
GUG
2124
Guggenheim Active Allocation Fund
GUG
$510M
| $40.4M | ﹤0.01% |
2,581,005
+109,208
| +4% | +$1.64M |
|
2125
iShares iBonds Dec 2032 Term Corporate ETF
IBDX
$1.7B
| $40.4M | ﹤0.01% |
1,596,453
+130,960
| +9% | +$3.25M |
|
Similar funds
Morgan Stanley's Q2 2025 Portfolio in Review
As of Q2 2025, Morgan Stanley held 8,401 positions worth $1.54T, up 9.8% from $1.4T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2025 filing shows 313 new, 3,923 increased, 2,951 reduced and 306 closed positions. Its largest new stake was JBS N.V.: 7,554,358 shares worth $110M. The largest sale was UnitedHealth, an estimated $2.39B.
By sector, the portfolio is most concentrated in Technology at 22% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
- Morgan Stanley's largest Q2 2025 buy was JBS N.V.: 7,554,358 shares worth $110M.
- Morgan Stanley added most to Vanguard Short-Term Bond ETF in Q2 2025, an estimated $1.77B increase.
- Morgan Stanley's biggest Q2 2025 reduction was UnitedHealth, cutting an estimated $2.39B.
- Morgan Stanley fully exited Discover Financial Services in Q2 2025, selling an estimated $786M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.54T portfolio in Q2 2025.
- Morgan Stanley opened 313 new positions and closed 306 in Q2 2025.
- Morgan Stanley's portfolio value rose 9.8% quarter-over-quarter to $1.54T.
Based on Morgan Stanley's 13F filing for Q2 2025, filed 15 Aug 2025.